Share on PinterestSetting a weight loss goal may yield greater success with GLP-1 drugs like Zepbound. Image Credit: Crispin la valiente/GettyImages A recent study found that people who set personal weight loss targets may achieve greater results with GLP-1 medications. People using tirzepatide (Zepbound or Mounjaro) saw more weight loss if they set goals or […]
Read MoreIntroduction and Objective: This study investigated the glucodynamics and hypoglycemia risk associated with exercise or fasting during once-weekly basal insulin icodec treatment.Methods: Thirty basal insulin-treated, physically active individuals with T2D were enrolled. Icodec was dosed for ≥7 wks to target FPG of 80-130 mg/dL. When icodec steady state was achieved, 40 min cycling (EXE; 60% […]
Read MoreIntroduction and Objective: FCL transcends reducing the burden of carbohydrate counting. FCL eliminates the need for meal management by the person with diabetes and restores the normal manner in which people without diabetes interact with food. That is a true freedom that people with diabetes have never known. A novel MiniMed™ FCL algorithm featuring personalized […]
Read More
Share on PinterestMayim Bialik recently shared the “nightmare” experience she had after using a GLP-1 drug. Image Credit: Laurent Koffel/Getty Images Actor Mayim Bialik has shared her “nightmare” experience that left her with weeks of side effects after one GLP-1 medication dose. Bialik said her symptoms included severe diarrhea and full-body aches. She revealed that […]
Read MoreIntroduction and Objective: Pakistan has the highest diabetes prevalence globally, with more than 34.5 million affected individuals—a figure projected to reach 62 million by 2045. 1,2 Currently, 1 in 4 adults has diabetes. Over 24 million adults with diabetes are not receiving treatment, meaning 67% of diabetics in the country are untreated. 4Objectives:Awareness campaigns to […]
Read MoreIntroduction and Objective: There is a decades old perception that women of African descent prefer large body sizes. Even though body size preference is a major determinant of health behavior, the 21st century view of body size preference in African immigrant (Afr-Im) and African American (AA) women is unknown. Our goal was to assess and […]
Read MoreIntroduction and Objective: Pancreatogenic diabetes (T3cDM) results from pancreatic exocrine dysfunction leading to endocrine insufficiency. Although linked to acute/chronic pancreatitis (AP/CP) and pancreatic cancer (PC), the incidence and predictors of diabetes after these conditions require clarification. This study determines the pooled incidence of new-onset diabetes following AP, CP, and PC and identifies disease-specific risk factors.Methods: […]
Read MoreIntroduction and Objective: Multidisciplinary obesity and diabetes care requires coordination across providers and multiple data sources, often involving extensive time on documentation and chart review. We evaluated whether implementation of a real-time, AI-generated structured patient summary could improve clinician efficiency and satisfaction.Methods: In a large nationwide virtual obesity clinic, we conducted a pre-post evaluation of […]
Read MoreIntroduction and Objective: miRNAs are emerging as significant metabolic regulators and are altered at both the cellular and secreted levels in diseases, including type 2 diabetes (T2D). However, to what extent alterations in miRNA content and secretion are cell-intrinsic, and how they play a role in disease pathogenesis, remains unclear.Methods: In the present study, we […]
Read MoreIntroduction and Objective: Exocrine pancreas dysfunction is evident in presymptomatic type 1 diabetes (T1D), yet its natural history remains unclear. We evaluated whether longitudinal decline in fecal elastase (FE-1) tracks more closely with islet autoimmunity or progression to dysglycemia and assessed its predictive utility.Methods: In a nested case-control study within The Environmental Determinants of Diabetes […]
Read More